Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
strategic options
Biotech
Phage-focused BiomX reset may include defense sector pivot
Phage-focused BiomX is undergoing a “strategic and financial reset” in efforts to improve the biotech’s financial position.
Gabrielle Masson
Mar 19, 2026 11:00am
Bicycle pumps brakes on lead program, deflates headcount by 30%
Mar 17, 2026 11:14am
Werewolf weighs sale or merger as cash reserves whimper
Feb 24, 2026 5:23pm
Cycle Pharma scoops up beleaguered rare disease biotech
Dec 12, 2025 9:55am
Charles River to cut costs, shift direction as revenue slides
Nov 5, 2025 12:54pm
Prelude calls it curtains on lead SMARCA2 cancer asset
Aug 14, 2025 10:44am
